The purposes of this pilot study are to evaluate the safety and efficacy of Botox® compared
to the safety and efficacy of oral baclofen in reducing muscle tone-related disability
resulting from neurological damage or a stable neurological disorder and to evaluate
drug-therapy tolerance.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center
Treatments:
abobotulinumtoxinA Baclofen Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA